The AlphaLISA® SureFire® Ultra™ Human Total BCL-2 assay is a sandwich immunoassay for quantitative detection of total BCL-2 in cellular lysates using Alpha Technology.
The oncogenic protein BCL-2 (B-cell lymphoma 2) is known for its role in preventing apoptosis. It is a 24-26 kDa protein that is found in the nuclear envelope, endoplasmic reticulum, and mitochondrial membrane. BCL-2 is categorized as a proto-oncogene since it is thought to be a significant antiapoptotic protein. Numerous cancers, such as breast, prostate, skin, colon, and pancreatic cancers, as well as neurological and autoimmune illnesses, have been linked to BCL-2 overexpression. The anti-apoptotic proteins BCL-XL, MCL-1, and BCL-W are all related. The BCL-2 family of proteins contains proapoptotic proteins such as Bax, BAD, Bak, Blk, and Bid.
The AlphaLISA SureFire Human Total BCL-2 Detection Kit is a sandwich immunoassay for the quantitative detection of total BCL-2 in cellular lysates, using Alpha Technology.
For research use only; not for diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption & disposal requirements under European REACH regulations (EC 1907/2006).
Application |
Protein Analysis & Detection
Protein Detection
|
---|---|
Assay Target Class |
Phospho-protein
|
Assay Technology |
Alpha
|
Automation Compatible |
Yes
|
Brand |
AlphaLISA SureFire Ultra
|
Detection Method |
Alpha
|
Experimental Type |
In vitro
|
Shipping Conditions |
Shipped in Blue Ice
|
Target Species |
Human
|
Therapeutic Area |
Oncology
|
Unit Size |
500 Assay Points
|
This guide outlines further possible optimization of cellular and immunoassay parameters to ensure the best possible results are...
Are you looking for technical documents for this product. We have housed them in a dedicated section., click on the links below to explore.
We are here to answer your questions.